Vir Biotechnology (VIR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VIR Vir Biotechnology

Watchlist

6.950
+0.210+3.12%

Close Nov 21 16:00 ET

7.110
+0.160+2.30%

Post 17:10 ET

957.15MMarket Cap-1768P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

J.P. Morgan Sticks to Their Hold Rating for Vir Biotechnology (VIR)
TipRanksNov 21 07:06 ET · Ratings
Leerink Partners Maintains Vir Biotechnology(VIR.US) With Buy Rating, Maintains Target Price $18
Moomoo NewsNov 21 01:31 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target
BenzingaNov 20 10:01 ET
TD Cowen Maintains Vir Biotechnology(VIR.US) With Buy Rating
Moomoo NewsNov 20 09:32 ET · Ratings
A Quick Look at Today's Ratings for Vir Biotechnology(VIR.US), With a Forecast Between $10 to $26
Moomoo NewsNov 20 08:00 ET · Ratings
TD Cowen Keeps Their Buy Rating on Vir Biotechnology (VIR)
TipRanksNov 20 07:26 ET · Ratings

Comments

NoNo444

Nov 18 21:10

$Vir Biotechnology (VIR.US)$ The graph looks funny...

Jaguar8

Nov 18 21:06

ADDED NEWS

$Vir Biotechnology (VIR.US)$
Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
Phase 3 Eclipse Program to Evaluate Tobevibart and Elebsiran

Stock_Drift

Nov 18 20:25

$Vir Biotechnology (VIR.US)$

Trytosaveabit

Nov 18 15:07

Update

$Vir Biotechnology (VIR.US)$ Reuters· just
Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta From European Medicines Agency